Last reviewed · How we verify
NCT04370106: legclub
The Impact of Frequenting a Social Leg Program on Therapeutic Adherence and Venous Leg Ulcer Wound Healing Outcomes
NA trial testing Social leg program in Venous Leg Ulcer in 268 participants. Status unknown.
30 March 2025
Quick facts
| Lead sponsor | School of Health Sciences Geneva |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 268 |
| Start date | 1 December 2023 |
| Primary completion | 30 March 2025 |
| Estimated completion | 31 August 2025 |
| Sites | 2 locations across Switzerland |
Drugs / interventions tested
- Social leg program
Conditions studied
- Venous Leg Ulcer — all drugs for Venous Leg Ulcer →
- Social Interaction — all drugs for Social Interaction →
Sponsor
School of Health Sciences Geneva
Who can join
18 and older, any sex, with Venous Leg Ulcer or Social Interaction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background and rationale: Venous leg ulcers (VLU) are slow healing wounds with a recurrence rate up to 70% and a 60% risk of becoming chronic. Currently the Swiss health care system does not take in consideration social and educational needs and support for VLU patients who transition from acute care (hospital care, outpatient care) to home based self-care. To fill this gap, this study proposes to create the Social Legs Program (SLP). Overall objectives: The objectives of the proposed study are to evaluate the impact of a frequented SLP for patients with VLU in terms of their therapeutic adherence and wound healing outcomes (wound size and wound recurrence). Methodology of the planned study: A randomized controlled trial with 268 participants in three Swiss French institutions is proposed. Expected results and impact: The findings of this study will generate new knowledge about support and care management of persons with VLU who transition between acute care settings and home care settings. The findings will contribute to the evidence base of clinical practice guidelines for the care of patients with VLU.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04370106
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Venous Leg Ulcer
Currently open trials in the same condition.
- NCT07255937 — PMCF Study of Debridement Pad · NA · recruiting
- NCT07046767 — CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations · NA · recruiting
- NCT07211243 — Suprasorb®X+PHMB Pro vs Suprasorb®X+PHMB in Treatment of Infected Venous Leg Ulcers · NA · recruiting
- NCT07061613 — Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Venous Leg Ulcers · NA · recruiting
- NCT06544564 — Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population · NA · recruiting
Other School of Health Sciences Geneva trials
Trials by the same sponsor.
- NCT07444151 — Post-Stroke Fatigue Perception Study (ReFast) · recruiting
- NCT07439367 — Multifocal Theta-Burst Stimulation to Enhance Upper Limb Motor Recovery After Stroke (INSPIRE) · NA · recruiting
- NCT05715190 — Development and Feasibility of a Nurse-led Person-centered Education Program · NA · enrolling by invitation
- NCT05912270 — Orchestra in Class, a Novel Booster for Executive Functions and Brain Development in Young Primary School Children · NA · recruiting
- NCT05740228 — Transcranial Direct Current Stimulation for Gait Recovery Following Stroke · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04370106 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by School of Health Sciences Geneva
- Last refreshed: 27 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04370106.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing